Wipro GE Healthcare Invests $960M in India

Wipro GE Healthcare, a collaboration between India’s Wipro Enterprises and the U.S.-based GE Healthcare, has announced a substantial investment of 80 billion rupees ($960 million) in India. This investment is earmarked for bolstering both manufacturing and research and development facilities over the next five years.

The Bengaluru-headquartered medical technology company unveiled its commitment on Tuesday, aligning with the government’s “Make in India” initiative. The focus lies on amplifying local manufacturing capabilities to strengthen its presence within the nation.

Part of this investment will facilitate the production of PET CT diagnostic scan devices within India, destined for export to 15 countries. PET CT scans, pivotal in diagnosing ailments like cancer, merge imaging techniques to delve into the body’s cellular functions.

Moreover, Wipro GE Healthcare divulged plans to locally manufacture other sophisticated medical technology devices, including CT scanners and MR breast coils.

Chaitanya Sarawate, Managing Director of Wipro GE Healthcare, affirmed the company’s dedication to advancing India’s healthcare agenda. He emphasized India’s ambition to ascend among the top five global manufacturing hubs for medical devices, pledging alignment with this national aspiration.

Established in 1990, Wipro GE Healthcare inaugurated a greenfield manufacturing unit in Bengaluru in 2022 under the government’s production-linked incentive scheme, designed to galvanize local investments and manufacturing.

With four manufacturing plants nestled in Bengaluru, renowned as India’s Silicon Valley, Wipro GE Healthcare underscores its commitment to further investment and global expansion, predominantly focusing on export services.